Your Cart ( 1 Item )

• Cost-Effectiveness Analysis of Ixekizumab vs Etanercept and Their Manufacturer-Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis
  October 2017 | Volume 16 | Issue 10 | Original Article | 964 | Copyright © October 2017
  Jeremy Udkoff MA MAS and Lawrence F. Eichenfield MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs